Pharmaceutical company licenses drug development compounds from 51ÁÔÆæ Research Foundation

MILWAUKEE_New Jersey-based RespireRx Pharmaceuticals Inc. has licensed a group of patented drug development compounds from the University of Wisconsin-Milwaukee Research Foundation. The newly licensed compounds, developed by the laboratory of James Cook, act on a particular neurotransmitter receptor in the brain, which has shown promise for treatment of epilepsy and other convulsant disorders. New drugs […]

Improving the public’s understanding of COVID-19 data in charts and graphs

MILWAUKEE_A 51ÁÔÆæ researcher is part of a team that is investigating how people interpret information about COVID-19 in graphs, maps and charts presented by the media. A team of scientists from four universities, including 51ÁÔÆæâ€™s Min Sook Park, has been awarded a RAPID grant from the National Science Foundation to investigate not only whether the […]

51ÁÔÆæ Research Foundation receives WEDC grant for 51ÁÔÆæ startups

MILWAUKEE_Leveraging a $200,000 matching grant from the Wisconsin Economic Development Corporation, the University of Wisconsin-Milwaukee Research Foundation has developed a Bridge Grant Program that will help commercialize innovations developed at 51ÁÔÆæ and contribute to the health of the local economy. The 51ÁÔÆæRF is working to raise funds to create a pool of $400,000 that will […]

NSF renews funding for study of ‘sustainable nanotechnology’

MILWAUKEE _ Nanoparticles are tiny bits of material – smaller than a blood cell – that are manufactured and integrated into a multitude of commercial products because of their unique properties. Nanomaterials can shed from the use or manufacture of these products into the environment and potentially cause problems. Scientists don’t know what happens inside […]